SCHEMBL20913331

SCHEMBL20913331

Cc1ccnc(Nc2ccc3cc(C)ccc3n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
KARS1 Q15046 8/20 0.47
KDR P35968 2/20 0.47
MAP4K4 O95819 1/20 0.47
ABL1 P00519 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
IGF1R P08069 1/20 0.47
LTK P29376 1/20 0.47
MAP2K2 P36507 1/20 0.47
MAPK8 P45983 1/20 0.47
MAPK9 P45984 1/20 0.47
CLK2 P49760 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47
CDK7 P50613 1/20 0.47
CDK9 P50750 1/20 0.47
CDK5 Q00535 1/20 0.47
MAP2K1 Q02750 1/20 0.47
ACVR1 Q04771 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20913338 0.88 KARS1 (0.55) KARS1KDRMAP4K4ABL1LCK
SCHEMBL20913337 0.88 SYK (0.49) KARS1KDRMAP4K4ABL1LCK
SCHEMBL20913328 0.88 MEN1 (0.47) KARS1KDRMAP4K4ABL1LCK
SCHEMBL1705870 0.88 NPC1 (0.47) KARS1KDRMAP4K4ABL1LCK
SCHEMBL1702364 0.86 MAPK8 (0.52) KARS1KDRMAP4K4ABL1LCK
SCHEMBL20913329 0.86 RIOK2 (0.51) KARS1KDRMAP4K4ABL1LCK
SCHEMBL27097211 0.83 KARS1 (0.52) KARS1KDRMAP4K4ABL1LCK
SCHEMBL20913317 0.82 MAPT (0.48) KARS1KDRABL1MAPK8CLK2
SCHEMBL2912518 0.80 KDR (0.57) KARS1KDRMAP4K4ABL1LCK
SCHEMBL30471870 0.77 CYP1A2 (0.61) CYP1A2NCK1BACE1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440546-B1 COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN PARTICULAR PROGERIA ABIVAX (FR) 2022-12-28 EP claimed
EP-2440547-B1 New chemical molecules that inhibit the splicing mechanism for the treatment of diseases resulting from splicing defects ABIVAX (FR) 2022-11-30 EP claimed
EP-2440545-B1 COMPOUNDS USEFUL FOR TREATING CANCER ABIVAX (FR) 2019-04-24 EP claimed